Insider Transactions in Q2 2024 at Hims & Hers Health, Inc. (HIMS)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 25
2024
|
Oluyemi Okupe Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
11,546
-6.11%
|
$254,012
$22.21 P/Share
|
|
Jun 25
2024
|
Soleil Boughton Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,335
-1.34%
|
$51,370
$22.18 P/Share
|
|
Jun 24
2024
|
Michael Chi Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
17,303
-8.54%
|
$380,666
$22.07 P/Share
|
|
Jun 24
2024
|
Michael Chi Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,303
+7.87%
|
$86,515
$5.01 P/Share
|
|
Jun 20
2024
|
Michael Chi Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
7,500
-3.89%
|
$180,000
$24.5 P/Share
|
|
Jun 20
2024
|
Michael Chi Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+3.74%
|
$97,500
$13.9 P/Share
|
|
Jun 20
2024
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
45,755
-23.01%
|
$1,052,365
$23.34 P/Share
|
|
Jun 18
2024
|
Michael Chi Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
25,549
-12.12%
|
$587,627
$23.59 P/Share
|
|
Jun 18
2024
|
Irene Becklund PAO |
SELL
Open market or private sale
|
Direct |
13,241
-81.97%
|
$304,543
$23.59 P/Share
|
|
Jun 17
2024
|
Irene Becklund PAO |
SELL
Open market or private sale
|
Direct |
472
-2.84%
|
$11,328
$24.1 P/Share
|
|
Jun 17
2024
|
Irene Becklund PAO |
BUY
Exercise of conversion of derivative security
|
Direct |
472
+2.76%
|
$4,248
$9.41 P/Share
|
|
Jun 14
2024
|
Oluyemi Okupe Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
51,561
-21.43%
|
$1,185,903
$23.75 P/Share
|
|
Jun 14
2024
|
Oluyemi Okupe Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
93,717
+28.04%
|
-
|
|
Jun 14
2024
|
Melissa Baird Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
28,778
-4.68%
|
$661,894
$23.75 P/Share
|
|
Jun 14
2024
|
Melissa Baird Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
73,146
+10.64%
|
-
|
|
Jun 14
2024
|
Andrew Dudum Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
97,052
-55.05%
|
$2,232,196
$23.75 P/Share
|
|
Jun 14
2024
|
Andrew Dudum Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
176,309
+50.0%
|
-
|
|
Jun 14
2024
|
Patrick Harrison Carroll Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,811
-1.84%
|
$87,653
$23.75 P/Share
|
|
Jun 14
2024
|
Patrick Harrison Carroll Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,987
+5.92%
|
-
|
|
Jun 14
2024
|
David B Wells Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,046
+5.12%
|
-
|
|
Jun 14
2024
|
Michael Chi Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
42,303
-16.71%
|
$972,969
$23.75 P/Share
|
|
Jun 14
2024
|
Michael Chi Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
76,506
+23.21%
|
-
|
|
Jun 14
2024
|
Irene Becklund PAO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,934
-32.94%
|
$182,482
$23.75 P/Share
|
|
Jun 14
2024
|
Irene Becklund PAO |
BUY
Exercise of conversion of derivative security
|
Direct |
24,088
+50.0%
|
-
|
|
Jun 14
2024
|
Soleil Boughton Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
23,739
-12.02%
|
$545,997
$23.75 P/Share
|
|
Jun 14
2024
|
Soleil Boughton Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
43,208
+17.95%
|
-
|
|
Jun 11
2024
|
Michael Chi Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
374,669
-67.96%
|
$8,242,718
$22.05 P/Share
|
|
Jun 11
2024
|
Michael Chi Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
374,669
+14.72%
|
$3,372,021
$9.32 P/Share
|
|
Jun 11
2024
|
Soleil Boughton Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,510
-1.6%
|
$52,710
$21.47 P/Share
|
|
Jun 10
2024
|
Michael Chi Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
17,571
-9.05%
|
$386,562
$22.01 P/Share
|
|
Jun 10
2024
|
Michael Chi Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,571
+2.27%
|
$158,139
$9.32 P/Share
|
|
Jun 06
2024
|
Alex Bard Director |
BUY
Exercise of conversion of derivative security
|
Direct |
19,707
+20.86%
|
-
|
|
Jun 06
2024
|
Oluyemi Okupe Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
98,635
-40.18%
|
$2,071,335
$21.42 P/Share
|
|
Jun 06
2024
|
Oluyemi Okupe Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
93,794
+14.78%
|
$750,352
$8.27 P/Share
|
|
Jun 06
2024
|
Ambar Bhattacharyya Director |
BUY
Exercise of conversion of derivative security
|
Direct |
19,707
+17.8%
|
-
|
|
Jun 06
2024
|
Patrick Harrison Carroll Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
19,707
+9.24%
|
-
|
|
Jun 06
2024
|
Christiane Pendarvis Director |
BUY
Exercise of conversion of derivative security
|
Direct |
19,707
+38.93%
|
-
|
|
Jun 06
2024
|
Garcia Andrea G Perez Director |
BUY
Exercise of conversion of derivative security
|
Direct |
19,707
+21.32%
|
-
|
|
Jun 06
2024
|
David B Wells Director |
BUY
Exercise of conversion of derivative security
|
Direct |
19,707
+10.07%
|
-
|
|
Jun 06
2024
|
Delos M. Cosgrove Director |
BUY
Exercise of conversion of derivative security
|
Direct |
19,707
+26.59%
|
-
|
|
Jun 06
2024
|
Lynne Chou O'Keefe Director |
BUY
Exercise of conversion of derivative security
|
Direct |
19,707
+50.0%
|
-
|
|
Jun 05
2024
|
Melissa Baird Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
17,625
-1.58%
|
$370,125
$21.46 P/Share
|
|
Jun 05
2024
|
Melissa Baird Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,625
+3.06%
|
$0
$0.4 P/Share
|
|
Jun 04
2024
|
Melissa Baird Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
17,625
-1.59%
|
$352,500
$20.4 P/Share
|
|
Jun 04
2024
|
Melissa Baird Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,625
+3.06%
|
$0
$0.4 P/Share
|
|
Jun 04
2024
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
144,444
-5.66%
|
$2,744,436
$19.93 P/Share
|
|
Jun 04
2024
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
188,888
-81.51%
|
$3,588,872
$19.93 P/Share
|
|
Jun 04
2024
|
Andrew Dudum Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
188,888
+50.0%
|
$377,776
$2.43 P/Share
|
|
Jun 03
2024
|
Melissa Baird Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
70,506
-5.82%
|
$1,410,120
$20.59 P/Share
|
|
Jun 03
2024
|
Melissa Baird Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
70,506
+10.33%
|
$0
$0.4 P/Share
|